Mirakof SR contains butamirate citrate, which acts centrally on the brain's cough center to suppress cough. It is a non-opioid, non-sedating agent with no chemical relation to opium alkaloids. After oral administration, it is rapidly and completely absorbed. The sustained-release formulation reaches peak plasma concentration in approximately 9 hours. It is highly protein-bound and has an elimination half-life of around 13 hours. Its active metabolites also contribute to its antitussive effect.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Mirakof SR is indicated for the relief of dry, non-productive cough, which may occur following viral infections. It is also used for pre- and post-operative cough suppression, including in patients undergoing procedures such as bronchoscopy. Additionally, it is effective in managing severe cough of various causes, including whooping cough and cough associated with lower respiratory tract conditions such as tracheitis, laryngitis, and bronchitis.
These usually resolve after dose reduction or discontinuation.
Adults:
Adolescents (>12 years):
Hypersensitivity to butamirate citrate or any component of the formulation
Store below 30°C, protected from light and moisture. Keep out of reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.